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Abstract: Since 2000, scientists and students from the greater Rocky Mountain region, along with
invited speakers, both national and international, have gathered at the Mountain Campus of Colorado
State University to discuss their area of study, present recent findings, establish or strengthen
collaborations, and mentor the next generation of virologists and prionologists through formal
presentations and informal discussions concerning science, grantsmanship and network development.
This year, approximately 100 people attended the 17th annual Rocky Mountain Virology Association
meeting, that began with a keynote presentation, and featured 29 oral and 35 poster presentations
covering RNA and DNA viruses, prions, virus-host interactions and guides to successful mentorship.
Since the keynote address focused on the structure and function of Zika and related flaviviruses,
a special session was held to discuss RNA control. The secluded meeting at the foot of the Colorado
Rocky Mountains gave ample time for in-depth discussions amid the peak of fall colors in the aspen
groves while the random bear provided excitement. On behalf of the Rocky Mountain Virology
Association, this report summarizes the >50 reports.
Keywords: prions; viruses; Dengue; Sinbis; CWD; Zika; metabolism; herpesvirus; primate; transmission

1. Introduction
As can be seen by a graph depicting the number of PubMed citations per year, advances in
virology and prion studies are accelerating at a pace that makes it difficult for any individual to remain
informed in areas outside one’s specialty (Figure 1). In addition, scientific meetings are continuing
to focus on specific areas to maximize dissemination of information to select groups while general
meetings that cover multiple fields are typically too large to permit prolonged informal discussion,
especially with students and early-stage investigators. With these facts in mind, the Rocky Mountain
Virology Association (RMVA) was formed to provide a venue that permitted formal presentations of
current research in multiple areas of virology and prion biology in a venue that is sufficiently removed
from major cities to ensure extended informal discussions and opportunities to establish/strengthen
collaborations. Professional child daycare was provided to help enable attendance by individuals with
young children, which provided an educational opportunity through the children’s participation in
Viruses 2017, 9, 333; doi:10.3390/v9110333
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2. Summary of Scientific Sessions
The tenor of the 2017 meeting was set with the keynote presentation provided by Richard J. Kuhn
(Department of Biological Sciences and Director, Purdue Institute of Inflammation, Immunology and
Infectious Disease, Purdue University) who described his team’s high resolution anatomical study
of flaviviruses. Zika virus emerged in 2015–2016 in the Americas, with rapid spread and substantial
impact. His team solved the structure of this flavivirus virion to near atomic resolution, and this
revealed the similarity with previous flavivirus structures such as dengue virus and West Nile virus.
Despite strong overall structural similarity, regions of the envelope (E) glycoprotein revealed differences
that suggested sequences that might be involved in the unique cell and tissue tropism that Zika has
displayed. Together with dengue virus, his team continued to probe the structure and composition
of these viruses and their assembly intermediates using the tools of cryo-electron microscopy and
mass spectrometry. In particular, they probed the process of virus particle maturation examining the
immature virus particle and the conversion of prM by cellular furin to the mature M form of the protein.
This process in dengue virus is very inefficient and they determined the stoichiometry of prM/M
proteins in the Zika virion, and evaluated the implications of the maturation state on virus biology.
Antibody binding to the particle has also been examined and has revealed insights into the process
of virus maturation as well as entry of the virion into target host cells. The ability to compare virus
particles from multiple members of the flavivirus genus in terms of structure and function serves as a
powerful strategy to discern common processes and distinct features that contribute to virus biology.
2.1. RNA Viruses
Reyes A. Murrieta (Arthropod-Borne and Infectious Diseases Laboratory, Department of
Microbiology, Immunology and Pathology, CVMBS, Colorado State University, Fort Collins, CO, USA)
described his work on the impact of environmental conditions on defining the population diversity of
Zika virus in Aedes mosquitoes. The emergence of arthropod-borne viruses (arboviruses) has become
an ever-growing public concern, highlighted by the recent emergence of Chikungunya virus and Zika
virus (ZIKV) in the Americas. The conditions that lead to the emergence of new virus genotypes are
poorly understood. In mosquitoes, temperature profoundly impacts virus transmission via replication
rate and the likelihood that virus will disseminate from the midgut and ultimately be transmitted.
Accordingly, they sought to define the impact of temperature on transmission dynamics of ZIKV and
determine whether temperature affects virus population structure during extrinsic incubation (EI)
in the mosquito. In particular, they exposed Aedes aegypti and Aedes albopictus mosquito vectors to a
bloodmeal containing a Puerto-Rican strain of Zika virus (ZIKV, Flaviviridae, Flavivirus) and held the
mosquitoes for 7 and 14 days at 25 ◦ C, 28 ◦ C and 35 ◦ C. They also exposed the infected mosquitoes to
fluctuating temperatures that varied from 25 to 35 ◦ C diurnally. They found that transmission of ZIKV
in both Aedes mosquitoes was most efficient at 28 ◦ C (p < 0.05). However, viral load in the midgut and
hemolymph was highest at 35 ◦ C (p < 0.05). Using RNA deep sequencing (RNAseq) to characterize
virus genetic diversity, they described that ZIKV populations in the midgut, hemolymph, and saliva
were shaped by the EI temperature. Collectively, their data indicated that temperature has multiple
impacts on ZIKV biology.
Claudia Rückert (Arthropod-borne and Infectious Diseases Laboratory, Department of
Microbiology, Immunology and Pathology, College of Veterinary Medicine and Biomedical Sciences,
Colorado State University, Fort Collins, CO, USA) described her work on the evolution of chikungunya,
dengue and Zika viruses in single, dual and triple infected Aedes aegypti mosquitoes. Recent evidence
suggests that coinfection with chikungunya (CHIKV), dengue (DENV) and Zika (ZIKV) viruses may
be relatively common in areas where all three viruses are co-circulating, including large parts of
the Americas. Here they showed that coinfection of Aedes aegypti (Poza Rica) mosquitoes with all
combinations of the three viruses is possible, and co-transmission may occur with little impact on
vector competence. Only subtle differences in vector competence were observed and viral load was
comparable in saliva. However, slightly reduced viral load was observed in coinfected mosquito
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bodies and legs. They were thus interested in characterizing interactions between the three viruses in
the mosquito. In order to understand how coinfection impacts virus evolution, Aedes aegypti (Poza Rica,
Mexico) were exposed to blood meals containing more than one Aedes-borne arbovirus. Specifically,
mosquitoes were orally exposed to American strains of CHIKV (99659), DENV-2 (Merida), or ZIKV
(PRVABC59) in single infections, as well as combinations of the three viruses as double and triple
infections. Mosquitoes were held for 12 days extrinsic incubation, at which time mosquito saliva,
salivary glands, legs and midguts were collected. Samples were processed for RNAseq on the Illumina
HiSeq4000 platform. They analyzed changes to viral consensus sequences and virus population
structure in single versus coinfected mosquito tissues. Overall, their data suggested that infection with
more than one arbovirus simultaneously may affect virus evolution in Aedes aegypti mosquitoes.
Rebekah C. Gullberg (Arthropod-borne and Infectious Diseases Laboratory, Department of
Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO, USA) initiated
a conversation about host lipids and their ability to alter the infectivity of dengue virus, serotype
2 particles. As obligate intracellular parasites with limited genetic capacity, viruses must find creative
ways to use cellular resources for their replication. Rearranging the structure of cellular membranes is a
key requirement for positive-strand RNA viruses. There are multiple ways to rearrange a phospholipid
membrane, such as controlling its source (e.g., particular organelle) or by altering cellular lipid
biosynthesis to concentrate or deplete a given lipid species. Dengue viruses are the most aggressive
arthropod-borne positive-strand RNA viruses in the world. It is well understood that dengue virus
type 2 (DENV2) alters fatty acid metabolism during infection in the mosquito and human hosts.
Fatty acids are a key component of endoplasmic reticulum (ER) membranes utilized for the viral life
cycle. The Perera lab showed that DENV specifically alters the content of unsaturated fatty acids
(UFA) in cellular membranes. In order to accomplish this, DENV2 upregulates and recruits Stearoyl
CoA-desaturase (SCD), the rate-limiting enzyme in UFA biosynthesis, early during infection to sites
of viral replication. Knockdown and inhibition of SCD resulted in reduced viral titers. Furthermore,
they found that in the absence of SCD activity, DENV2 was less infectious in the next round of infection
which led to the hypothesis that the virus titer reduction was due to a change in the content of the lipid
envelope, which produced immature particles. Despite the lack of virus-derived lipid biosynthetic
machinery, DENV2 was able to drastically alter cellular lipid content by manipulating SCD expression
and thus produce mature virions. Hence they speculate that UFA biosynthesis pathway is a promising
target for therapeutic intervention.
Nunya Chotiwan (Arthropod-borne and Infectious Diseases Laboratory, Department. of
Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO, USA) continued
the conversation on host lipids during dengue virus infection and presented data on how the ceramide
and dihydroceramide ratio could impair dengue virus serotype 2 infection of Aedes aegypti-derived
cells. Sphingolipids (SPs) are bioactive molecules that play roles in the structural composition of
cellular membranes and cell-signaling pathways. SPs have also been highlighted in many studies
as a lipid metabolic pathway altered by flavivirus infection. In the metabolomics study of midguts
from Aedes aegypti mosquitoes infected with dengue virus (DENV) type 2, The Chotiwan lab identified
and reconstructed a significant proportion of the SP pathway. This was the first functional annotation
and validation of the pathway. They observed an accumulation of precursors and downstream
derivatives of ceramide (CER), a hub of the SP pathway, during DENV infection. The balance between
CER and its precursor, dihydroceramide (DHCER), plays critical roles in membrane architecture,
fluidity and function. Therefore, they investigated whether modulation of CER and DHCER levels
and the CER/DHCER ratio would have an impact on DENV infection in Aedes aegypti-derived cells
using loss-of-function studies and validated the changes in metabolites by tandem mass-spectrometry.
Cells were treated with 4-Hydroxyphenyl Retinamide (4HPR) or long double-stranded RNA (dsRNA)
to inhibit activity of or knockdown the expression of sphingolipid ∆-4 desaturase (DEGS), the enzyme
that converts DHCER to CER. Inhibition of DESG by 4HPR showed significant reduction of virus titer
and genome replication but did not alter CER/DHCER ratios. However, DESG expression knockdown
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by dsRNA reduced DENV infection and altered CER/DHCER ratios. These results indicated that
functionality of DEGS is important for DENV infection and the balance of CER and DHCER is a
potential target for disrupting DENV transmission in Aedes aegypti mosquitoes.
Kirsten Krieger (Arthropod-borne and Infectious Diseases Laboratory, Department. of
Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO, USA) kept
the “lipid-centric” conversation going and described how phosphatidylcholine-enriched membrane
environments influenced the replication of dengue viruses. Dengue Viruses (DENV) are positive strand
RNA viruses that account for almost 400 million infections annually making them the most aggressive
arthropod-borne human pathogens in the world. Positive strand RNA viruses share the common
characteristic of reorganizing host cellular phospholipid membranes to assemble their viral replication
complexes (VRCs). Unfortunately, how these viruses regulate membrane reorganization is unknown.
During DENV replication, dramatic changes occur in lipid biosynthesis, that have a significant impact
on membrane architecture and cellular signaling pathways. Phosphatidylcholine (PC) is a major
phospholipid component of many lipoproteins, and makes up about 50% of total phospholipid content
in cellular membranes. PC is synthesized in the endoplasmic reticulum via two distinct pathways:
the Kennedy pathway or the PEMT pathway. The Kennedy pathway, abundant in most tissues,
includes a crucial step in which phosphocholine is converted to CDP-choline by the enzyme, CTP:
phosphocholine cytidylyltransferase (CCTalpha). CCTalpha, encoded by the PCYT1A gene, is the
rate-limiting enzyme for PC synthesis. Studies on Brome Mosaic Virus (BMV), another positive strand
RNA virus, have shown that BMV stimulates PC synthesis at viral replication sites. It has also been
documented that PC accumulates in DENV infected mosquitoes and mosquito cells as well as during
Hepatitis C and poliovirus infection. Preliminary results by the Krieger lab supported their hypothesis
that dengue virus uses the CCTalpha enzyme to increase and regulate phosphatidylcholine synthesis
during viral replication in order to change the lipid composition of host cellular membranes to benefit
the viral life cycle.
Jenna Read (Arthropod-borne and Infectious Diseases Laboratory, Department. of Microbiology,
Immunology and Pathology, Colorado State University, Fort Collins, CO, USA) provided an update
concerning fatty acid chain elongation in human cells impacting on the replication of dengue virus,
serotype 2. Dengue viruses (DENV) are arthropod borne viruses with widespread impact consisting
of 390 million new cases every year. Due to a geographical shift in arbovirus spread, viruses such as
West Nile, dengue, and now Zika are becoming increasing threats to the United States. In order to
develop antiviral or therapeutic agents, it is important to understand how the virus interacts with the
host to initiate infection, replication and transmission. As obligate parasites, viruses require metabolic
resources from host cells for productive infection. Many viruses including DENV impact the flux from
glucose to acetyl-CoA to feed fatty acid metabolism in infected cells. For this purpose, they hijack
several enzymes responsible for the biosynthesis or degradation of fatty acids. Saturated very-long
chain fatty acids (VLCF) are one group of fatty acids that are hijacked by many viruses. Mammals
have seven elongase enzymes to synthesize saturated VLCFs. Preliminary data on dengue virus has
indicated that Elongation of Long-Chain Fatty Acid Family Member 6 (ELOVL6) is important for
virus replication. ELOVL6 has been identified as a rate limiting enzyme that catalyzes the elongation
of saturated and unsaturated long-chain fatty acids. These fatty acids can be used as precursors for
more complex cellular membrane lipid production. The Read lab is validating the role of this enzyme
during dengue virus replication under the hypothesis that dengue virus requires ELOVL6 to increase
membrane fluidity and support the formation of membrane-bound virus replication complexes,
and that blocking the activity of ELOVL6 may be a potential avenue for antiviral intervention.
Elena Lian (Arthropod-borne and Infectious Diseases Laboratory, Department. of Microbiology,
Immunology and Pathology, Colorado State University, Fort Collins, CO, USA) presented preliminary
data on using fatty acid desaturase 2 (FADS2) enzyme activity as a control point to limit dengue virus
serotype 2 replication. Dengue is an arthropod-borne viral disease with an estimated 400 million
infections annually across the globe. Dengue fever is caused by dengue viruses (DENV) and despite the
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prevalence of this disease, there are currently no US Food and Drug Administration (FDA)-approved
vaccines or antivirals. DENV has been shown to manipulate the host’s lipid biosynthesis pathways,
specifically that of unsaturated fatty acids, for the assembly and function of viral replication complexes.
Lipids are also used as cell signaling molecules for purposes such as antiviral defense mechanisms.
By controlling lipid biosynthesis, DENV can better evade the host’s immune response. One of the major
lipid pathways altered by DENV is alpha-linolenic acid and linoleic acid metabolism. Arachidonic
acid is one of the products from this pathway, and is an inflammatory molecule involved in cell
signaling. Since DENV incites an inflammatory response, this pathway is an ideal drug target. Fatty
acid desaturase (FADS2) is the rate-limiting enzyme used to catalyze the pathway; therefore, it is a
potential target to reduce DENV replication. Preliminary evidence indicated a reduction in DENV
replication in human cells through the inhibition of FADS2. To test the hypothesis that inhibition of
FADS2 will impede DENV replication by reducing the presence of arachidonic acid in the cell from
linoleic acid metabolism, the Lian lab plans to further investigate how inhibition of FADS2, with an
inhibitor and with siRNA, will affect DENV, as well as cellular viability and function.
Stephanie Mills (Arthropod-borne and Infectious Diseases Laboratory, Department. of
Microbiology, Immunology and Pathology and Department of Biological Sciences, Colorado State
University, Fort Collins, CO, USA) discussed the potential of using Acyl-CoA thioesterases as restriction
factors of dengue viruses. Although dengue viruses (DENV) infect over 400 million people per year,
only a suboptimal vaccine exists, and other therapeutic options are unavailable. Previous studies
indicate that DENV utilizes lipids to replicate in host cells and preliminary loss of function analyses of
fatty acid metabolizing enzymes identified Acyl-CoA thioesterase-1 (ACOT-1) to significantly increase
DENV particle release. ACOT-1, a 42 kDa enzyme which hydrolyzes C-12 to C-20 length Acyl-CoA fatty
acids, has been shown to reduce sepsis and prevent diabetes. The Mills’ lab analyzed the role ACOT-1
in the life cycle of DENV. They harvested Huh-7 cells infected with DENV at 3 h intervals for 48 h.
Uninfected cells and UV-inactivated DENV-exposed cells were included as controls. They analyzed
ACOT-1 protein levels compared to viral protein NS3 in cell lysates on western blots and also analyzed
the impact of siRNA mediated knockdown of ACOT-1 on DENV RNA replication by electroporating a
luciferase reporter-tagged viral replicon following siRNA treatment. Validation of ACOT-1 messenger
RNA (mRNA) levels in knockdown and control cells were done by quantitative real-time polymerase
chain reaction (qRT-PCR). Localization of ACOT-1 protein upon infection was determined using
immunofluorescence microscopy. Although ACOT-1 mRNA levels were inconclusive, ACOT-1 protein
levels increased and then spiked between 9 and 12 h post infection, before decreasing to base line
levels 21 h post infection. DENV RNA levels increased five-fold above controls upon siRNA mediated
knockdown of ACOT-1. However, unlike other fatty acid metabolizing enzymes in DENV infected
cells, ACOT-1 did not co-localize with NS3 upon infection. Their results indicated there was an increase
in DENV particle release and genome replication upon loss of ACOT-1 function. Therefore, ACOT-1
may be the first fatty acid enzyme that plays a protective role in host cells against DENV infection.
Caroline Montgomery (Arthropod-borne and Infectious Diseases Laboratory, Department of
Microbiology, Immunology and Pathology and Department of Biological Sciences, Colorado State
University, Fort Collins, CO, USA) described her analysis of exosomes released from Zika virus
infected cells as a paracrine signaling mechanism to prime neighboring cells for enhanced infection.
Cell-to-cell communication has the capacity to enhance viral infection by releasing signaling molecules
or vesicles from infected cells that prime recipient cells. One way these communication pathways
can function is by giving an advantage to the virus as it replicates by priming the neighboring cells
and making them more susceptible to infection. The signaling molecules can circulate in the host and
give way to prolonged consequences of infection. These molecules are referred to as the secretome
of cells and may contain lipids, nucleic acids and proteins and can be transported by extracellular
vesicles. For example, fatty acid synthase (FAS), which is an important enzyme in lipid metabolic
pathways, can be transported by extracellular vesicles to increase the metabolism of the recipient cells.
FAS is required in the viral lifecycle, and through transport by these vesicles, it can metabolically
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activate the recipient cells and prime them for infection. Through this observation, it is suggested that
infected cells can participate in paracrine signaling, thus enhancing viral replication in neighboring
cells. Under the hypothesis that vesicles released by ZIKV infection will enhance the metabolism of
neighboring cells, thus increasing the ability of ZIKV to replicate in these cells, the Montgomery lab
presented preliminary data concerning secretome of ZIKV infected cells to determine whether they are
able to participate in paracrine metabolic activation.
Alison Gilchrist (Department of Molecular, Cellular, Developmental Biology and the Biofrontiers
Institute, University of Colorado, Boulder, CO, USA) shifted the conversation to host protein targets
predicted to be cleaved by the dengue virus protease. Dengue virus translates its genome into a
single polyprotein and uses a self-encoded protease to cleave the polyprotein into individual proteins.
The target site specificity for this protease is loose, so The Gilchrist lab anticipated that it also cleaved
some host proteins in a manner that may be important for the viral life cycle. Using a machine learning
approach, they have created a predictor to search for Dengue protease cleavage sites within the human
proteome. They have experimentally validated that several human proteins in this candidate list
were cleaved by the Dengue protease, and were important for replication. They provided insight
now that each of these host-virus interactions may be acting as species-barriers in the movement
of viruses between primate species, and which of these genes may be evolving rapidly in primate
populations; information that was tested experimentally with different orthologs in Dengue infection
assays. This project demonstrated how analysis tools from the field of molecular evolution could help
facilitate novel characterization of host-virus biology.
Abhilash Chiramel (National Institute of Health/Rocky Mountain Laboratories, Hamilton,
MT, USA) introduced the audience to the concept that human TRIM5 protein could function as a
host-derived restriction factor for flaviviruses. Tripartite motif (TRIM) proteins are interferon-inducible
genes (ISGs) and function as virus- and host-specific restriction factors that can interact with viral
proteins and inhibit viral replication. Flaviviruses, include globally significant human pathogens such
as tick-borne encephalitis virus (TBEV), West Nile virus (WNV) and dengue virus. TBEV replication is
inhibited by TRIM30D, a rodent-specific ISG that functions by binding and targeting the viral RNA
polymerase (NS5) for lysosomal degradation. TRIM5 a retrovirus-specific restriction factor is the closest
human paralog of TRIM30D. The Chiramel lab showed that both human (h) and rhesus (rh) TRIM5
restricted the replication of viruses belonging to the TBEV serogroup, but not WNV. Ectopic expression
rhTRIM5 on TBEV significantly reduced the production of infectious virus by more than 99%. hTRIM5
overexpression imposed a 90% reduction of virus titer, whereas knock-down of hTRIM5 partially
rescued the antiviral effects of interferon treatment. TRIM5 reduced production of both viral RNA and
protein, indicating that TRIM5 targeted an early step in virus replication. However, unlike TRIM30D,
TRIM5 did not interact with NS5 and instead interacts with and degrades NS3, an RNA helicase
critical to virus replication, by a mechanism involving the proteasome. Moreover, TRIM5 colocalized
with NS3 and dsRNA suggesting that TRIM5 disrupts the viral replication complex. This work
demonstrated that TRIM5 could target two very different viral proteins, the human immunodeficiency
virus (HIV) capsid, and the TBEV helicase. Understanding the genetic trade-offs in TRIM5 that enable
restriction of one virus versus another will illuminate how the evolution of host resistance is shaped
by multiple pathogens.
Cody J. Warren (BioFrontiers Institute, Department of Molecular, Cellular, and Developmental
Biology, University of Colorado Boulder, CO, USA) discussed his work on the cluster of differentiation
4 (CD4) receptor and how it restricts cellular entry of human immunodeficiency virus (HIV)-1 in
nonhuman primates. Acute-stage isolates of HIV-1 require two receptors to enter cells, CD4 and C-C
chemokine receptor type 5 (CCR5). The surface glycoprotein of HIV-1, Envelope (Env), mediates
interaction with these two receptors facilitating virus entry into cells. The Warren lab showed that
HIV-1 is highly adapted to use human CD4, and that nonhuman primate forms of CD4 restrict HIV-1
entry. Interestingly, HIV-1 poorly enters cells bearing even chimpanzee or gorilla CD4, despite the
close relationship of these species to humans. They identified the reason why this important host
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restriction in nonhuman primates has been underappreciated to date: virions bearing Envs commonly
used in SHIVs (SIV/HIV chimeric viruses), which are isolated from chronic-stages of infection and
often are laboratory-adapted, efficiently infect cells expressing both human and nonhuman primate
CD4 receptors. The finding that HIV-1 is highly adapted to humans in its use of CD4 has the potential
to impact how HIV-1 infection and transmission is modeled in nonhuman primates.
Joseph A. Westrich (Department of Immunology and Microbiology, University of Colorado
School of Medicine, Aurora, CO, USA) provided evidence that the high-risk human papillomavirus E7
stabilizes the APOBEC3A protein by inhibiting Cullin-dependent protein degradation. Recent studies
have revealed abundant APOBEC3 signature mutations in human papillomavirus (HPV)-positive
cervical and head and neck cancers, suggesting a role in HPV-positive cancer progression. The Westrich
lab and others have shown that A3A, a member of the APOBEC3 family, is upregulated in HPV-positive
keratinocytes and cancer patient tissues. They sought to determine if the HPV oncoprotein E7 had
a post-translational effect on the A3A protein, thus they determined A3A protein levels in human
keratinocytes expressing various HPV E7s. They found that high-risk HPV (HPV16 and 18) E7s,
but not low-risk HPV (HPV6 and 11) E7s, inhibit A3A proteasomal degradation, effectively stabilizing
the A3A protein. This effect was mediated by the motifs in the domain of HPV16 E7 involved with
interaction with Cullin 2 (CUL2), a core component of the E3 ubiquitin ligase complex. Knockdown
of CUL2, or inhibition of Cullin activation, resulted in protecting A3A from degradation similar to
high-risk E7-expressing cells. CUL2 was shown to interact with both A3A and E7, suggesting CUL2 as
a key player in preventing A3A degradation. Using an in vitro cytidine deaminase assay, they showed
that the A3A protein stabilized by HPV16 E7 maintained its enzymatic activity to deaminate cytidine.
These findings that high-risk HPV E7 stabilizes A3A protein provide a new insight into virus-induced
mutagenesis that may contribute to the generation of APOBEC3 mutation signatures observed in
HPV-positive cancers.
Emily Anne Kizer (University of Idaho, ID, USA) discussed the identification of novel antibiotics
from satellite viruses. Increasing levels of drug resistance in human pathogenic yeasts stress the need
for to develop new antifungal drugs. The Kizer lab has screened 216 yeasts from the Saccharomyces
genus and identified 30 strains capable of producing protein toxins that inhibit the growth of fungi,
including other Saccharomyces yeasts and several human pathogens from the genus Candida. They have
found that 77% of these newly identified “killer yeasts” were infected with viruses from the Totiviridae
family. Of these virus-infected killer yeasts, 93% contained double-stranded RNA (dsRNA) satellites,
which have been previously shown to encode antifungal toxins. The molecular weight and copy
number of these dsRNA satellites varies within each killer yeast. The antifungal toxins produced
by each identified killer yeast have the ability to inhibit growth of a unique subset of Saccharomyces
and pathogenic yeast strains. They hypothesized that sequence polymorphisms found within dsRNA
satellites were responsible for the variation in toxin tropism. To explore the relationship between
genotype and antifungal toxin efficacy, they developed a rapid method for dsRNA extraction and
next-generation sequencing. Using this pipeline, they have successfully identified several novel
totiviruses and toxin-encoding dsRNA satellites. The expressed cloned toxin genes from dsRNAs in
the laboratory yeast S. cerevisiae, recapitulating their antifungal activity. This was the first study to
investigate the role of dsRNA satellites in the production of antifungal toxins and to relate dsRNA
satellite sequence to the killer yeast phenotype.
2.2. DNA Viruses
Keith W. Jarosinski (Department of Pathobiology, College of Veterinary Medicine, University
of Illinois at Urbana-Champaign, Champaign, IL, USA) described his lab’s studies to identify
host-specificity during herpesvirus host-to-host transmission, with the overall goal of understanding
the mechanism by which viral and host proteins facilitate efficient transmission from host-to-host.
Transmission from host-to-host (interindividual spread) is an essential component in the herpesvirus’
life cycle. Herpesviruses are typically associated with a single host species in nature, but when they
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transmit across species (interspecies spread), the outcome is often deadly. For example, the macaque
herpes B virus causes fatal encephalitis when transmitted to humans, and Aujeszky’s disease in cattle
is caused by Suid alphaherpesvirus 1 (SuHV1), better known as pseudorabies virus (PRV), naturally
found in pigs. However, very little is known about transmission of herpesviruses. He described his
lab’s successful work that culminated in identification of two herpesvirus proteins that are essential for
interindividual spread of Gallid alphaherpesvirus 2 (GaHV-2), better known as Marek’s disease virus
(MDV), in chickens-namely, glycoprotein C (gC) that is conserved among the Alphaherpesvirinae
subfamily and the conserved herpesvirus protein kinase (CHPK) conserved among all members of the
Herpesviridae family.
Myrna M. Miller (University of Wyoming, Wyoming State Vet Lab, Laramie, WY, USA) continued
the theme of herpesviruses in natural hosts by presenting her group’s study of seroprevalence of a novel
mule deer-associated alphaherpesvirus in Wyoming. A previously unidentified alphaherpesvirus
was found in juvenile mule deer (Odocoileus hemionus) that were submitted to the Wyoming State
Veterinary Laboratory with infectious keratoconjunctivitis-like syndrome (IKC) and/or blindness.
A retrospective analysis of IKC cases between 2000 and 2016 in mule deer found that 23% (4/17) were
associated with this herpesvirus. Whole-genome sequencing of four isolates found that they were
identical (>99.8% identity). Phylogenic analysis based on amino acid sequences for glycoproteins gB,
gC, and gD showed this mule deer-derived herpesvirus (MDHV) is most closely related to ruminant
alphaherpesviruses, including cervid herpesvirus-1 (CvHV-1, 93% identity), cervid herpesvirus 2 and
bovine herpesvirus 1 (CvHV-2, BHV-1, 91% identity), BHV-5 and buffalo herpesvirus (90% identity),
and caprine herpesvirus (86% identity). BHV-1 is the prototype for ruminant alphaherpesviruses
and causes respiratory and reproductive syndromes in cattle, including rhinotracheitis, conjunctivitis,
encephalitis, and abortion. The distribution and prevalence, as well as the range of clinical syndromes
caused by MDHV, are currently unknown. A seroepidemiologic survey was performed to establish the
prevalence of MDHV infection in three Wyoming herd units. Microtiter serum neutralization assays
were used with mule deer serum against MDHV or BHV-1. The prevalence of anti-MDHV antibodies
in these three herds was 84% (67/80, CI 90%, 77–91%), 90% (66/73, CI 90%, 84–96%), and 76% (68/89,
CL 90%, 69–83%). Serologic cross-reactions with BHV-1 were detected, but titers were significantly
lower (p values </= 0.008) based on paired students t-test. MDHV is highly prevalent in Wyoming
mule deer and cross-reacts with BHV-1 at significantly lower titers.
Linda F. van Dyk (Department of Immunology and Microbiology, University of Colorado School
of Medicine, Aurora, CO, USA) presented her lab’s work using a mouse model to study human
herpesvirus disease. Gammaherpesviruses (γHV), including Epstein-Barr virus, Kaposi’s sarcoma
associated herpesvirus (KSHV) and murine γHV68, exploit lymphocytes as their lifelong reservoir.
Previously, the van Dyk lab demonstrated that a conserved viral homolog of cellular cyclins (v-cyclin)
is critical for specific aspects of γHV68 infection. The v-cyclin is critically required for reactivation from
latency, viral persistence, and disease progression, including tumor development, yet is dispensable
for viral replication and establishment of latency. They found that v-cyclin function in reactivation
was complemented by the v-cyclin of KSHV and by host cyclin D3, but not by other related cyclins.
Additionally, they found that the v-cyclin promoted reactivation from latency by specific antagonism
of host cyclin dependent kinase inhibitor, p18INK4C (p18). Infection of p18 null mice with a v-cyclin
deficient virus (cycKO) restored reactivation from latency to near wild-type virus levels, and using
a recombinant γHV68 virus that expressed host p18 in place of the v-cyclin (p18KI) resulted in
significantly suppressed reactivation beyond that of the cycKO virus. The cyclin D/p18 regulatory
hub was critically required for normal B cell development and differentiation, and was disrupted in
many B cell lymphomas. This research further characterizes the specific interplay between distinct
cyclin functions and host p18 in virus reactivation, and illustrates the therapeutic potential of targeting
host p18 to manipulate virus infection and associated disease.
Elizabeth A. Fortunato (Department of Biological Sciences and Center for Reproductive Biology,
University of Idaho, Moscow, Idaho, USA) continued the theme of host-virus interactions and disease
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caused by herpesvirus infection by presenting her work showing that human cytomegalovirus (HCMV)
controls cellular nidogen 1 protein levels and its implication on the developing fetus. HCMV congenital
infection in the US affects ~1% of newborns annually. Five to 10% of congenitally infected infants
display negative central nervous system consequences at birth and another 10–15% develop sequelae
within the next few years, principally sensorineural hearing loss. Malfunctioning of the nervous system
later in childhood indicates a prolonged viral interaction or propagation of a deficiency. Her lab’s
observation of infection-induced DNA damage to chromosome 1, at 1q23 and 1q42, indicated distinct
interactions of HCMV with the cellular DNA. Fine-mapping of the 1q42 breaksite revealed Nidogen 1
(NID1), an important basement membrane protein, was encoded in the region. NID1 is expressed by
many cells within the developing brain and has been shown to be important for neuronal migration,
optic cup morphogenesis and neural network excitability and plasticity. Downregulation of NID1
expression could have negative ramifications for an infected fetus. They now find that NID1 is
downregulated not only transcriptionally, but also at the post-translational level. pp71 is bound to
the DNA at the 1q42 breaksite and the NID1 promoter leading her to suspect it, in conjunction with
the insulator protein CTCF, is responsible for transcriptional regulation. NID1 protein levels are also
decreased after ∆pp71 virus infection. The targeting of NID1 by two separate viral proteins via two
separate pathways highlights the importance of NID1’s elimination to the virus. She concluded by
describing her future plans that will focus on characterizing the NID1 targeting mechanisms, defining
the benefits of NID1 downregulation to viral infection, and defining the negative ramifications of NID1
downregulation to an infected fetus.
Teresa Mescher (Department of Neurology, University of Colorado School of Medicine, Aurora,
CO, USA) described work providing a mechanistic pathway through which the neurotropic
alphaherpesvirus, varicella zoster virus, may contribute to the development of a serious disease in the
aging human population. Giant cell arteritis (GCA) is an inflammatory vascular disease of the elderly
that has been shown to be highly associated with varicella zoster virus (VZV) infection of the temporal
artery (TA) [1–3]. GCA is pathologically defined as having transmural inflammation, medial necrosis,
and giant and/or epithelioid cells. Interleukin (IL)-8 is an inflammatory cytokine that when released,
calls in neutrophils to the site of an infection. IL-8 is upregulated in the cerebral spinal fluid (CSF) of
patients with VZV vasculopathy [4], and in VZV-infected primary human vascular cells in vitro [5].
Based on these findings and on the presence of abundant VZV antigen in GCA, 20 GCA-positive
(patients with clinical and laboratory features of GCA whose TA biopsies are pathologically positive
for GCA), 20 GCA-negative (patients with clinical and laboratory features of GCA whose TA biopsies
are pathologically negative for GCA), and 18 normal TAs were stained for the presence of IL-8 and
neutrophils (CD15). Immunohistochemical analysis revealed interleukin 8 (IL-8) antigen in 17/20
(85%) GCA-positive, 18/20 (90%) GCA-negative, and 2/18 (11%) normal TAs. CD15 antigen was
also seen in 20/20 (100%) GCA-positive, 18/20 (90%) GCA-negative, and 3/18 (17%) normal TAs.
IL-8 appears to be upregulated in both GCA-positive and -negative TAs compared to normal TAs.
The upregulation of IL8 is also consistent with the presence of neutrophils in all GCA-positive TAs
and most GCA-negative TAs. This finding further shows that GCA is an immunopathological disease
caused by VZV reactivation in the cranial ganglia and subsequent infection of the TA.
Christina Como (University of Colorado School of Medicine, Aurora, CO, USA) presented
her progress in developing and in vitro model of varicella zoster virus latency. Varicella zoster
virus (VZV) is an alphaherpesvirus that causes varicella (chicken pox) and establishes latency in
sensory neurons along the entire human neuraxis. Virus reactivation is commonly observed in the
elderly and immunosuppressed individuals and results typically in shingles, but can also cause
postherpetic neuralgia, vasculopathy, and ocular diseases. Although there is a vaccine to mitigate
varicella, the vaccine is a live attenuated virus that can still enter latency and reactivate to cause
disease. Currently, there is no animal model available to study VZV, making it important to design
a cell model for latency and reactivation. It is hypothesized that a persistent release of cytokines
suppresses virus and contributes to latency in human neurons. We hypothesize that VZV-infected
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neurons treated with cytokines will establish latency in vitro. Our results suggest interleukin 6 (IL-6),
tumor necrosis factor (TNF)-α, interferon alpha (IFNα), and IFNβ individually aid in limiting VZV
growth and spread. This provides a better understanding of the relationship between the immune
system, human neurons, and VZV latency. Using this model and understanding these interactions
may lead to treatment options for patients experiencing VZV pathology.
Nicholas Baird (Departments of Neurology University of Colorado School of Medicine, Aurora,
CO, USA) expanded on the in vitro neuronal culture model to develop a system to investigate
the molecular events involved in virus-induced pain. Varicella zoster virus, an alphaherpesvirus,
infects and establishes latency in sensory, autonomic, sympathetic and parasympathetic neurons
during primary infection (varicella; chickenpox). Decades later, Varicella zoster virus (VZV) can
reactivate to cause a multitude of neurological disorders including zoster (shingles) and post-herpetic
neuralgia (PHN), pain lasting months to years following resolution of zosteriform rash. His model
for virus-induced pain involved differentiating a human dorsal root ganglion cell line, HD10.6 into
nociceptive sensory neurons which express βIII-tubulin, peripherin and sodium channels 1.7 & 1.8.
Importantly, the differentiated cells express substance P and NK1, a molecule and receptor involved in
signaling and sensing nociceptive pain. These cells were permissive to VZV infection, that culminated
in the production of infectious virus. Together, this new model system is poised to begin understanding
the molecular mechanisms underpinning the pains of zoster and PHN.
Anna Blackmon (University of Colorado, School of Medicine, Aurora, CO, USA) presented
data describing studies to investigate how a nehrotorpic alphaherpesvirus could exit the neuron
during virus reactivation. Varicella zoster virus (VZV) vasculopathy occurs after virus reactivates
from ganglia, spreads along nerve fibers to arteries, leading to pathological vascular remodeling
and stroke. An interesting observation in temporal arteries from VZV vasculopathy patients was
the presence of VZV antigen in cells surrounding nerve fibers in the outermost adventitial layer.
Immunohistochemistry revealed that these VZV-infected cells expressed the tight junction protein
claudin-1, identifying them as perineurial cells which form a barrier between the peripheral nerve
and surrounding tissue. Her lab hypothesized that during VZV spread along nerve fibers, the virus
may disrupt tight junctions in perineurial cells, potentiating infection of surrounding vascular cells.
To test this hypothesis, they mock- and VZV-infected primary human perineurial cells (HPNCs)
and compared expression and distribution of cell adhesion proteins (claudin-1, E-cadherin and
N-cadherin) at three days post-infection. While there was no VZV-induced changes in claudin-1
transcripts compared to mock-infected HPNCs, claudin-1 redistributed from the membrane/cytoplasm
to the nucleus. When HPNCs were treated with anti-claudin-1 or isotype control antibodies prior to
VZV-infection, there was no difference in the level of virus infection. Furthermore, while mock-infected
cells expressed E-cadherin and not N-cadherin, VZV-infected cells did not express E-cadherin but
expressed N-cadherin-supporting the novel possibility of a VZV-induced epithelial-mesenchymal cell
transition. Addition of conditioned media from VZV- or mock-infected HPNCs to uninfected HPNCs
showed that the conditioned media from VZV-infected cells contained a soluble factor that was able to
induce the same changes seen in VZV-infected cells. Overall, their findings suggest that: (1) claudin-1
is not necessary for VZV infection and (2) VZV-induced redistribution of claudin-1, downregulation of
E-cadherin and upregulation of N-cadherin is mediated by a soluble factor and may lead to disruption
of tight junctions in perineurial cells, allowing viral spread from nerve fibers to surrounding vascular
cells in VZV vasculopathy.
Catherine Pearce (Department of Neurology, University of Colorado School of Medicine, Aurora,
CO, USA) presented a study describing how varicella zoster virus alters lipid metabolism in human
sensory neurons and permissive human lung fibroblast cells. Varicella zoster virus (VZV) is an
alphaherpesvirus that upon primary infection causes a dermatomal rash in skin fibroblasts, after which
it becomes latent in ganglionic neurons. Statins have been a major advancement in the prevention of
cardiovascular disease; however, patients who take this medication to reduce cholesterol levels appear
to experience an increased risk of VZV reactivation, the cause of shingles. How statins and cholesterol
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levels influence VZV reactivation in latently-infected ganglionic neurons is unknown. To better
understand the relationship between cholesterol metabolism and VZV infection in neurons and
fibroblasts, The Baird lab performed a microarray-based gene analysis of lipoprotein and cholesterol
metabolism pathways. Their results showed that VZV infection modulates expression of genes
involved in cholesterol metabolism and lipoprotein signaling in both human neurons and fibroblast
cells. Further studies were described to help elucidate mechanisms of how VZV-infection may
alter lipid metabolism for a better understanding of why patients on statins are more likely to
experience zoster.
Claire Birkenheuer (Louisiana State University, Baton Rouge, LA, USA) showed high resolution
mapping of host RNA polymerase II following herpes simplex virus type 1 infection, to more clearly
understand how the virus repatriates the enzyme for viral transcription. Precision nuclear run-on
(Pro-seq) is used to map RNA Polymerase II (Pol II) location on actively transcribed genomes to a
single base pair resolution. Using this technique, the Baines’ lab characterized Pol II occupancy on
host genes 3 h post-infection with herpes simplex virus 1 (HSV-1). Their data shows that even at this
early time point Pol II is removed from most host genes. However, they also noted gene-specific effects
in which HSV-1 increases Pol II occupancy and modulates its location at every stage of transcription:
from Pol II recruitment and initiation, to promoter proximal pausing, elongation, and termination.
To assess the effects of this modulation, the Baines’ lab used quantitative reverse transcription PCR
(qRT-PCR) with total RNA, nuclear messenger RNA (mRNA), and cytoplasmic mRNA to analyze
transcript levels of STUB1, USP8, MYC, EGR1, FOSB, c-FOS, and JUNB. Most genes with increased Pol
II occupancy or recruitment had higher levels of total RNA and nuclear mRNA. In contrast, termination
extension usually decreased cytoplasmic mRNA levels. Functional clustering revealed a profile that,
they hypothesize, reflects a cellular environment permissible for virus replication. Thus, HSV-1 reduces
host gene expression, working in combination with the virion host shut-off protein (vhs) in some cases,
while ramping up host gene transcription to transcend the effects of vhs in other cases. They note that
Pro-seq overcomes technical difficulties associated with Pol II chromatin immune precipitation and
sequencing while providing higher resolution, and holds promise for use with other viruses that alter
Pol II activity.
Addilynn Beach (University of Colorado School of Medicine, Denver, CO, USA) also investigated
virus gene transcript, but at the level of transcription initiation. Specifically, she searched for chromatin
insulator binding on the virus genome during latency to determine how the virus genes are silenced
in human neurons. Herpes simplex virus type 1 and varicella zoster virus are ubiquitous human
neurotropic alphaherpesviruses that establish life-long latent infection in trigeminal ganglia following
primary infection. During latency, most virus genes are transcriptionally silenced by posttranscriptional
modifications of bound histone proteins. Current thought suggests that the epigenetic markings on the
latent virus genome are segregated by chromatin insulators, especially the CTCF-binding factor (CTCF).
To develop a topological profile of alphaherpesviruses genome in multiple human trigeminal ganglia,
a set of tilled oligonucleotides were used to enrich virus sequences in chromatin immunoprecipitation
assays targeting CTCF-protein. Analysis of human DNA within the enriched sample described
definite peaks at known CTCF-motifs located at cell gene promoters. Analysis of virus DNA within
the samples showed read clusters enriched at CTCF-motifs. It is hoped that our consensus portrait
of CTCF occupancy on alphaherpesviruses in human trigeminal ganglia will provide clues to the
mechanism by which virus gene transcription is controlled during latency and reactivation.
2.3. Prion Disease
Thomas E. Eckland (Medical Microbiology and Immunology, Creighton University in Omaha,
NE, USA) introduced prion disease, and how prion strain interactions during incubation periods affect
strain dynamics. Prion diseases are a group of inevitably fatal neurodegenerative diseases affecting
mammals, including humans. Prion diseases are caused by a misfolded isoform of the prion protein,
PrPSc . Prion strains are operationally defined a heritable phenotype of disease under controlled
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transmission conditions that are hypothesized to be encoded by strain-specific conformations of PrPSc .
Prion strains can interfere with each other when a long incubation period strain (i.e., blocking strain)
inhibits the replication of a short incubation period strain (i.e., non-blocking). Prion strain interference
influences prion strain dynamics and the emergence of a strain from a mixture. However, it is unknown
if two long incubation period strains can interfere with each other. To investigate this, they used
a combination of protein misfolding cyclic amplification strain interference (PMCAsi) and animal
bioassay. Using PMCAsi, they found a PrPSc migration pattern consistent of a mixture of both strains,
suggesting that strain interference is not occurring. Animal bioassay experiments are consistent with
these in vitro findings. This is the first example of prion strain combinations that do not interfere with
each other both in vitro and in vivo. This observation changes the paradigm of the interactions of
prion strains in a mixture and has implication for interspecies transmission and emergence of prion
strains from a mixture.
Kaitlyn Miedema (Department of Microbiology, Immunology and Pathology, Colorado State
University in Fort Collins, CO, USA) described the role of plants in transmission of chronic wasting
disease (CWD). Recent work has found both internal and external plant surfaces are able to bind
and retain infectious prions, suggesting plants may play an important role in prion transmission.
To expand on these findings, the Zabel lab exposed rice plants (Oryza sativa L., cultivar kitaake) to a
solution containing 1% of a brain homogenate from a terminally ill elk for either 2 h, 24 h or 72 h.
Tissues were collected by cutting the leaves, stem and roots and were then homogenized to a 10%
(w/v) homogenate and tested for chronic wasting disease prions (PrPCWD ) by protein misfolding
cyclic amplification (PMCA). After PMCA, we were able to detect PrPCWD in root and leaf tissue of
experimentally exposed rice plants by 2 h post exposure (hpe). At 24 hpe, PrPCWD was detected in
root tissues after PMCA. No positivity was detected by PMCA at 72 hpe. In addition to laboratory
manipulations, we wanted to investigate whether plants were contaminated with PrPCWD in a natural
setting. Two sites were identified in Rocky Mountain National Park (RMNP) and plants were collected
using disposable spades. Plant surfaces were washed and wash solution was tested for PrPCWD by
PMCA. After washing and decontamination, plants were homogenized to test for the presence of
PrPCWD on internal structures. We detected PrPCWD from the surface of two plants at a single location
in RMNP after six rounds of PMCA. None of the internal tissues were positive by PMCA. These results
provide new insights into the role of plants in CWD transmission.
Erin McNulty (Department of Microbiology, Immunology and Pathology, Colorado State
University in Fort Collins, CO, USA) presented progress on in vitro prion detection methodology
throughout clinical prion disease. Prion infectivity can be transmitted in blood during symptomatic
and asymptomatic disease phases of Creutzfeldt-Jakob disease (vCJD)-infected humans, and chronic
wasting disease (CWD), bovine spongiform encephalopathy (BSE) and scrapie-infected animals. It is
currently estimated that ~1:2000 individuals in the United Kingdom are asymptomatic carriers of
vCJD. CWD continues to demonstrate geographic expansion, now found in captive and free-range
cervid populations in North America, South Korea, and Norway. Progress in developing in vitro
detection assays for hematogenous prions has been hampered by the presence of inhibitors found
in blood that interfere with detection methodologies. The development of antemortem detection of
blood-borne prions for humans, cervids and other susceptible species is of utmost importance for
human public health, animal monitoring of prions, and improved understanding of intra/inter-host
trafficking and pathogenesis. Their previous work demonstrated CWD prion infectivity and an ability
to detect prions by in vitro methodology in blood throughout the protracted disease course. Here they
corroborated and improved upon these findings by use of blood buffy coat cells and superparamagnetic
iron oxide beads (IOMB) in combination with real time quaking-induced conversion (RT-QuIC).
They have demonstrated prions by IOMB-RT-QuIC in blood harvested minutes post prion exposure
(15 min, 30 min, 60 min, one week, two weeks, n = 8 deer with 16 replicates/animal/time) through
clinical disease (n = 7 deer, with 24–36 replicates/animal). This methodology will: (i) enhance
our ability to determine the role of blood-borne prions in establishing and maintaining infection;
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as well as (ii) identify which specific blood cell phenotype subsets traffic/amplify prions through the
disease course.
Candace Mathiason (Colorado State University, Fort Collins, CO, USA) continued the theme
of pathogen and host interactions through a presentation of their use of real time quaking-induced
conversion (RT-QuIC) to detect blood-borne prions in buffy coat cells harvested from longitudinal
chronic wasting disease (CWD) infection studies. Prion infectivity has been transmitted in blood
during symptomatic and asymptomatic disease phases of Creutzfeldt-Jakob disease (vCJD)-infected
humans, and CWD, bovine spongiform encephalopathy (BSE), and scrapie-infected animals. It is
currently estimated that ~1:2000 individuals in the United Kingdom are asymptomatic carriers of
vCJD. CWD continues to demonstrate geographic expansion, now found in captive and free-range
cervid populations in North America, South Korea, and Norway. Progress in developing in vitro
detection assays for hematogenous prions has been hampered by the presence of inhibitors found
in blood that interfere with detection methodologies. The development of antemortem detection of
blood-borne prions for humans, cervids and other susceptible species is of utmost importance for
human public health, animal monitoring of prions, and improved understanding of intra/inter-host
trafficking and pathogenesis. Their previous work demonstrated CWD prion infectivity and an
ability to detect prions by in vitro methodology in blood throughout the protracted disease course.
Here they corroborated and improved upon these findings by use of blood buffy coat cells and
superparamagnetic iron oxide beads (IOMB) in combination with RT-QuIC. They demonstrated
prions by IOMB-RT-QuIC in blood harvested minutes post prion exposure (15 min, 30 min, 60 min,
1 week, 2 weeks, n = 8 deer with 16 replicates/animal/time) through clinical disease (n = 7 deer,
with 24–36 replicates/animal). This methodology will: (i) enhance our ability to determine the role of
blood-borne prions in establishing and maintaining infection; as well as (ii) identify which specific
blood cell phenotype subsets traffic/amplify prions through the disease course.
Byron Caughey (Rocky Mountain Laboratories, NIAID, NIH, in Hamilton, MT, USA) described
ultra-sensitive assays for prions and prion-like misfolded protein aggregates. Many neurodegenerative
diseases involve the pathological accumulation of fibrillar aggregates of specific proteins such as Aβ
and tau in Alzheimer’s disease; tau in frontotemporal dementias, chronic traumatic encephalopathy
and other tauopathies; αSynuclein in Parkinson’s and other synucleinopathies; and prion protein
(PrP) in prion diseases. In these diseases, the protein aggregates propagate within, and sometimes
between, hosts through seeded polymerization mechanisms. A major clinical problem is the inability
to accurately discriminate and diagnose many of these diseases, which can have complex and
overlapping clinical manifestations, while patients are still alive. We and others are exploiting the
basic propagation mechanisms of various misfolded protein aggregates in vitro to develop accurate
antemortem diagnostic tests based on etiological biomarkers. Multiple large independent studies have
now shown 92–100% sensitivity and nearly 100% specificity of second generation (IQ-CSF) RT-QuIC
assays in the diagnosis of sporadic Creutzfeldt-Jakob disease using cerebrospinal fluid and/or nasal
swab samples. RT-QuIC assays for most other prion diseases of humans and animals have also
been developed and are undergoing further evaluation. Analogous prototypic RT-QuIC and protein
misfolding cyclic amplification (PMCA) assays for tauopathies and synucleinopathies have also begun
to appear. For example, they have developed a tau RT-QuIC assay that can detect ~billion-fold dilutions
of brain tissue from human cases with a type of tauopathy (Pick’s disease) with a high degree of
sensitivity and specificity relative to other types of tauopathies. Collectively these seeded fibrillization
assays for disease-specific and pathological protein aggregate biomarkers have the potential to greatly
improve the development of diagnostics and therapeutics for multiple neurodegenerative protein
misfolding diseases.
2.4. RNA Control
Richard E. Lloyd (Department of Molecular Virology and Microbiology, Baylor College of
Medicine, Houston, TX, USA) described RNA granules and how these unique cytoplasmic structures
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may cross-talk with the innate immunity system. Two types of dynamic cytoplasmic RNA granules
are conserved from yeast to mammals. Stress granules (SGs) contain stalled translation initiation
complexes, and processing bodies (PBs) are enriched with RNA decay factors. Since both types of
RNA granules sequester translationally silenced mRNAs, RNA viruses antagonize RNA granules
for replicative advantages. Enteroviruses and other picornaviruses repress SG and PB formation via
multiple mechanisms, however, enteroviruses principally block SG through cleavage of the dominant
SG-nucleating factor Ras GTPase-activating protein-binding protein 1 (G3BP1). The Lloyd lab has
shown that G3BP1 functions as an activator of innate immunity via stress-induced recruitment of
PKR to SGs and also activates NF-κB. In addition, G3BP1 undergoes reversible phosphorylation and
methylation changes during stress and recovery which are required for G3BP1 to nucleate stress
granules, and which regulate innate immune activation. These findings support an emerging concept
that SGs function as signaling platforms to activate or enhance innate immunity and better define the
antagonistic relationship of viruses with RNA granules.
Nicholas Meyerson (BioFrontiers Institute, University of Colorado, Boulder, CO, USA) described
how cellular Tripartite motif-containing protein 25 (TRIM25) senses and restricts the Influenza A Virus
ribonucleoprotein complex. The human genome encodes approximately 100 TRIM E3 ubiquitin ligases.
Although many TRIMs have been linked to viral infection, detailed mechanisms are known for only
a small number. TRIM25 is a component of the RIG-I signaling cascade that activates the interferon
response upon sensing foreign viral RNA. The Meyerson lab described a novel function of TRIM25
whereby it inhibited influenza viral RNA synthesis in a direct manner, which was independent of
its ubiquitin ligase activity and of the interferon response in general. Therefore TRIM25 is a bona
fide restriction factor that blocks virus replication directly without the need for extensive signaling.
The mechanism by which TRIM25 inhibits viral RNA synthesis is unique. TRIM25 senses and binds
vRNPs, the influenza structures which contain viral genome segments. Their results provide strong
evidence that TRIM25 acts as a molecular clamp that impedes movement of the viral RNA template into
the polymerase. By this mechanism TRIM25 does not directly inhibit polymerase activity, but rather
deprives the polymerase of access to the viral RNA template. Furthermore, they find that the restriction
factor activity of TRIM25 is specific to influenza viruses and is antagonized by the influenza virus
accessory protein NS1. They have also shown that TRIM25 has evolved under positive selection in both
mammalian and avian species that are regularly infected with influenza. This unique evolutionary
signature results from recurrent antagonism by viruses and suggests that TRIM25 may act as a barrier
to the cross-species transmission of influenza viruses in the wild.
Justin Lee (Colorado State University, Fort Collins, CO, USA) described new advances in
next-generation nucleic acid sequencing through the introduction of MinION; a platform especially
useful for assembling RNA virus genomes in remote research stations. The MinION by Oxford
Nanopore Technologies Inc. is the first portable next-generation sequencing (NGS) instrument and is
capable of producing long-reads of single molecules from DNA and RNA libraries. The NGS Facility
in the Department of Microbiology, Immunology and Pathology at Colorado State University has a
MinION instrument and has recently performed pilot testing of this instrument to better understand
its capabilities and limitations. They obtained sequence data from bacterial and eukaryotic genomic
DNA on the MinION and on an Illumina MiSeq. The MinION runs produced reads ranging from
less than 1 kb to over 500 kb in length with an error rate of approximately 25%. Output from a single
run was sufficient to assemble a complete draft 6 Mbp bacterial genome sequence in one contig, with
adequate depth to minimize the effect of the high error rate. A hybrid assembly incorporating long and
short reads produced a near perfect assembly of the bacterial genome. Output from a single MinION
run produced only ~0.1× coverage over a bat genome, and thus was not sufficient to assemble the
genome. They conclude that the MinION is a valuable tool for small genome sequencing and for
producing long reads to span areas of low complexity that don’t assemble well with short-read data
alone. The low upfront cost and portability of the instrument also make it a possibly useful tool for
field and surveillance applications.
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Benjamin M. Akiyama (Department of Biochemistry and Molecular Genetics, University of
Colorado Denver School of Medicine, Aurora, CO, USA) described nuclease resistant non-coding RNA
in Zika virus. The outbreak of Zika virus (ZIKV) and associated fetal microcephaly mandates efforts to
understand the molecular processes of infection by this emerging global pathogen. Related flaviviruses,
including Dengue and West Nile virus, produce unique non-coding RNAs known as subgenomic
flaviviral RNAs (sfRNAs). sfRNAs are highly conserved and have been linked to the pathology of
the virus in cell culture and mouse model systems. sfRNAs are formed by co-opting Xrn1, the cell’s
predominant 50 →30 exonuclease. The viral RNA genome contains highly structured Xrn1-resistant
RNAs (xrRNAs), which halt the enzyme leaving sfRNAs behind. While the biology of sfRNAs has been
explored in other flaviviruses, the existence of sfRNAs or xrRNAs during ZIKV infection has not been
reported. The Akiyama lab demonstrated that ZIKV infection in multiple cell types results in distinct
sfRNA patterns. They solved the structure of a ZIKV xrRNA responsible for sfRNA production in
these cell types. The complete ZIKV xrRNA structure reveals how xrRNAs resist the helicase activity of
Xrn1, using two intertwined RNA pseudoknots which form a molecular “slipknot.” Furthermore, the
ZIKV xrRNA structure provides a model for understanding Xrn1-xrRNA interactions, and identifies
conserved features that modulate function in diverse pathogenic flaviviruses.
Colleen L. Watkins (Department of Biochemistry and Molecular Biology, Colorado State
University, Fort Collins, CO, USA) described the role of picornaviral polymerase finger domains in
RNA binding and translocation. The picornavirus family of viruses includes poliovirus, the causative
agent of paralytic polio and coxsackievirus, which is responsible for viral-heart-disease. Picornaviruses
contain a single-stranded positive-sense RNA genome replicated by 3 Dpol, an RNA-dependent
RNA polymerase (RdRP). Crystal structures of 3Dpol from multiple picornaviruses have shown a
conserved polymerase fold analogous to a “right hand” composed of fingers, palm and thumb domains.
A previous study in coxsackievirus showed mutations within the RdRP palm domain resulted in
changes to both fidelity and elongation rate, with slower replicating RdRPs having a higher fidelity
and lower fidelity RdRPs replicating faster [6]. Mutations in the fingers domain primarily changed
the rate with less of an effect on fidelity. This finding led to the hypothesis that regulation of speed
and fidelity are controlled by different regions within the RdRP, with the rate of translocation being
controlled by the fingers domain as an entire unit. To address this, a set of chimeric polymerases based
on poliovirus and coxsackievirus 3Dpols have been constructed by exchanging the fingers domains
entirely or only the pinky finger motif between the two viral polymerases, and the hybrid 3 Dpols were
characterized. The data suggest determinants of RNA binding are contained within the polymerase
pinky finger, while elongation complex stability is established by the polymerase core. Significant
effects to translocation are not seen, likely due to active site closure by the wild type polymerase cores
remaining the rate limiting step in the catalytic cycle.
Anna-Lena Steckelberg (University of Colorado, Denver, CO, USA) showed how viral RNA
was protected from 50 –30 exoribonucleolytic decay by enzyme-assisted RNA folding. RNA viruses
generally have short genomes and encode only a few proteins, thus they have evolved elegant
RNA-based strategies to manipulate cellular processes and thereby enhance virus propagation.
An interesting illustrative example is found in plant-infecting Dianthoviruses, which generate
viral non-coding RNAs through the selective protection of their 30 untranslated region (UTR) from
50 –30 exonucleolytic decay. The Steckelberg lab discovered that a 44-nucleotide structured RNA
element at the beginning of the viral 30 UTR was sufficient to inhibit 50 –30 exonucleolytic decay
in vitro. They solved the three-dimensional structure of a complete Dianthovirus nuclease-resistant
RNA (xrRNA) by X-ray crystallography, revealing that it forms a stem loop structure which is
held in a distorted “tilted” conformation through several long-distance base-stacking interactions.
Base pairs formed between adjacent molecules in the crystal structure indicate that this Dianthovirus
xrRNA can adopt two mutually exclusive conformations, and functional assays with mutant RNAs
confirm that both conformations are required for nuclease resistance. These data suggest that the
xrRNA element functions as a structural switch, triggered by the arrival of an exonuclease from the
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50 direction. Whereas the tilted stem-loop structure likely represents a necessary folding intermediate,
the actual nuclease-resistant structure contains a pseudoknot formed between the 30 end of the
structure and the loop sequence, which generates a ring-like fold that protectively wraps around
the 50 end of the structure. A similar ring-like shield around the 50 end of RNA is found in the
nuclease-resistant RNA structures of arthropod-borne flaviviruses (such as Dengue and Zika virus);
although the folding strategies used to form the two structures are very different. Even though the
overall fold of flaviviral and dianthoviral nuclease-resistant RNAs differs greatly, this observation
highlights how highly divergent RNA viruses have developed similar RNA-based strategies to inhibit
exoribonucleases, and suggests that manipulation of nuclease activity through RNA structure might
be a widespread mechanism.
Zoe G. O’Donoghue (Department of Biochemistry & Molecular Genetics, University of Colorado
Anschutz Medical Campus, Aurora, CO, USA) explored and characterized the pathogenically relevant
RNA structures in Flaviviruses. Flaviviruses like Dengue, Zika, and West Nile infect millions of people
every year making them prominent global health threats. Broadly speaking, the family flaviviridae
contains enveloped viruses that are vector borne and have positive sense, single stranded RNA
genomes. Throughout infection viral replication produces large quantities of genomic RNA, but the
accumulation of smaller regions of the highly structured viral 30 untranslated region (UTR) is also
observed. These subgenomic Flaviviral RNAs (sfRNAs) are made via incomplete degradation of the
viral genome by the host 50 to 30 exonuclease Xrn1, and previous studies show that sfRNA formation
is dependent upon the presence of highly structured and conserved regions of the 30 UTR called
Xrn1 resistant RNAs (xrRNAs). sfRNAs have been shown to be necessary for both cytopathicity and
pathogenicity during West Nile virus (WNV) infection. Using a reconstituted in vitro study system,
the Kieft lab has demonstrated that several alternate members of the flaviviridae family, including
Modoc (MODV), Montana Myotis Leukoencephalitis (MMLV), Cell Fusing Agent (CFAV), and Tick
Borne Encephalitis (TBEV) viruses, also produce sfRNAs following Xrn1 degradation. Further, using
selective 20 hydroxyl acylation analyzed by primer extension (SHAPE) chemical probing they have
been able to characterize these evolutionarily diverse xrRNAs into two distinct structural “classes”,
indicating that while the ability to produce sfRNAs may be conserved across the flavivirus genus,
the sequences required for Xrn1 halting are more variable than previously suspected. This observation
may imply a generalized role for sfRNAs during flavivirus infections and currently they are working
to more fully characterize the structural mechanism(s) of enzyme halting in these different classes
of xrRNAs. Additionally, they have found that the halt sites in the 30 UTR of WNV are capable of
stopping other exonucleases as well, including bacterial enzyme RNase J1. Ongoing studies also
include infection models and large-scale manipulations of xrRNAs in the Dengue Virus 30 UTR to
explore the structure-function mechanisms of sfRNAs during infection in both mosquito vector and
vertebrate host models.
Tony Schountz (Department of Microbiology, Immunology and Pathology, College of Veterinary
Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO, USA) presented
information concerning the experimental infection of Jamaican Fruit Bats (Artibeus jamaicensis) with a
rescued bat HL18NL11 Influenza A-like virus. Recently, nucleotide sequencing led to the discovery
of the presence of two novel influenza A-like viruses, HL17NL10 and HL18NL11, in New World
little yellow shouldered fruit bats (Sturnira lilium) and flat-faced fruit bats (Artibeus planirostris),
respectively. Serological studies indicated high prevalence to these viruses among many species of
Phyllostomidae leaf-nosed fruit bats of Central and South America, including Jamaican fruit bats
(Artibeus jamaicensis). Infectious viruses have not been isolated from bats: therefore an infectious clone
of HL18NL11 was generated by reverse genetics technologies that produced particles resembling
influenza viruses from transfected cells by electron microscopy. The Schountz lab sought to determine
susceptibility of Jamaican fruit bats to rescued HL18NL11 bat influenza A-like virus. During a 28 day
challenge experiment with intranasal inoculation, the bats exhibited no clinical signs of disease.
However, rectal swabs had up to 104 TCID50 equivalents of HL18NL11 viral RNA (vRNA) by real-time
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PCR in each bat on days 2, 4 and 7 post-inoculation, and in the lungs of one of the bats on day
28 when they were euthanized. Histopathology revealed minimal evidence of disease except for
the one bat with detectable vRNA in its lung. This bat’s lungs had aggregates of macrophages
and lymphoplasmacytes intermixed with fewer neutrophils that expanded into the interstitium,
especially around the adventitia. Immunohistochemistry with mouse antibody to recombinant H18N11
nucleoprotein revealed virus antigen in the lungs of this bat. This work represents the first study
demonstrating animal susceptibility to bat influenza viruses and suggests that viral persistence up to
28 days occurs in some bats; data supporting the hypothesis that Jamaican fruit bats may be a natural
reservoir host of the HL18NL11 virus. They are currently conducting additional infection studies of
Jamaican fruit bats with HL18NL11 to further characterize the virology and immunology.
Scott King (School of Pharmacy, Department of Pharmaceutical Sciences, Regis University,
Denver, CO, USA) presented the intriguing finding of antibody responses to influenza in adults
with Down syndrome. Adults with Down syndrome (DS) are particularly susceptible to respiratory
infections, and respiratory disease is a primary cause of death in individuals with DS over the age of
20 years. Although no studies to date have identified the pathogens responsible for the majority of
respiratory infections observed in adults with DS, data from previous influenza epidemics suggest
that individuals with DS have significantly higher rates of morbidity and mortality as a result of
influenza infection. Data evaluating the effectiveness of immunizations in individuals with DS is
limited and inconclusive, although it has been established that those with DS have decreased B cell
counts. Herein, the King lab hypothesized that adults with DS will have an attenuated antibody
response to immunization. Antibody titers to influenza A, influenza B and Bordetella pertussis were
evaluated using a standard enzyme-linked immunosorbent assay (ELISA). Their results demonstrated
that adults with DS had decreased antibody titers to influenza B and pertussis toxin. Interestingly,
adults with DS had significantly increased IgG antibody titer to Influenza A compared to age matched
controls (p value = 0.005). They hypothesize that this may be due to adults with DS acquiring a
subclinical influenza A infection despite immunization.
2.5. Pathogen-Host Interactions
Nicholas A. Bergren (Colorado State University, Fort Collins, CO, USA) investigated the ability
of a recombinant vesicular stomatitis-Zaire ebola virus vaccine candidate to transmit in arthropods.
From 2013 thru 2016 an unprecedented outbreak of ebola virus (EBOV) occurred in West Africa.
This outbreak highlighted EBOV’s ability to cause massive epidemic events and the need for a safe
and efficacious vaccine that protects against ebola virus disease for health care workers and people of
endemic regions. The V920 vaccine, being developed by Merck & Co., Inc., Kenilworth, NJ, USA and
NewLink Genetics (Ames, IA, USA), is a live, replication-competent vesicular stomatitis virus-Indiana
(VSV-I) where the VSV glycoprotein (G) gene is replaced with the glycoprotein of Zaire-EBOV (ZEBOV).
The vaccine has been tested in numerous Phase 1–3 clinical trials, and the data suggest that the vaccine
is generally well tolerated and effective at preventing ebola virus disease. Since the V920 vaccine
candidate is constructed using the backbone of an arbovirus, studies evaluating the potential for V920
to replicate and transmit in arthropods are necessary. To accomplish this, they assessed the ability
of V920 to replicate in several sandfly and mosquito cell lines, intra-thoracically (IT) inoculated and
blood-fed Aedes aegypti and Culex quinquefasciatus. A wild-type VSV-I was used as a positive control
and a VSV-I vectored vaccine against Semliki Forest virus (rVSV-SFV) was used as a comparator in
all experiments. All viruses are replication competent in Vero cells. V920 was unable to replicate in
relevant cell types or to transmit in relevant arthropod vector species, supporting a low environmental
risk of this vaccine. Their work was funded by the Defense Threat Reduction Agency.
Wendy Maury (Dept. Microbiology and Immunology, University of Iowa, Iowa City, IA, USA)
presented information concerning the control of Ebola virus infection by the polarization status of
macrophages. During Ebola virus (EBOV) infection, macrophages and dendritic cells have been shown
to be the first cells within the body that are virus antigen positive. Further, these cell populations
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are thought to support EBOV replication over the course of infection, resulting in the production of
dysregulated cytokines/chemokines. As tissue macrophages are known to have a number of different
phenotypes depending on their environment, The Maury lab sought to determine the effect of the
phenotype on the ability of macrophages to support EBOV. Using both a BSL2 model virus of EBOV
(EBOV GP/rVSV) and wild-type EBOV, they found that macrophages treated with interferon gamma
(IFN-γ), causing an M1 cellular phenotype, profoundly inhibited EBOV infection. Consistent with this,
IFN-γ-treated murine peritoneal macrophages transferred into a naïve mouse were protected against
lethal virus challenge. In contrast, treatments that shift a macrophage towards an M2 phenotype,
such as IL-4/-13, enhanced EBOV GP/rVSV infection. Enhanced infection at least in part was due to
IL-4/-13-stimulated expression of C-type lectins on the surface of the cells, known surface receptors
for filoviruses. Upregulation of these C-type lectins resulted in greater entry of EBOV GP/rVSV into
primary peritoneal macrophages and human monocyte derived macrophages. Finally, they found that
introduction of IL-4/-13-treated peritoneal macrophages into naïve mice exacerbated EBOV GP/rVSV
morbidity and mortality. In total, their findings were the first demonstration that the environment of
the EBOV-infected macrophage determines the permissiveness of the cell to filoviruses and supports
previous findings that macrophages are a critical cell population in determining EBOV pathogenesis.
Nathaniel Byers (Centers for Disease Control and Prevention, Fort Collins, CO, USA) presented
a method for longitudinal mosquito saliva collection for determining arbovirus vector competence
that increases biosafety and throughput. The recent emergence of Zika, chikungunya and yellow-fever
viruses emphasizes the need for rapid, reliable, and safe methods for analyzing vector competence
from various species of mosquitoes. Arboviruses transmit from the mosquito to the vertebrate host via
mosquito saliva; hence, collecting mosquito saliva to assess viral titers is an essential activity. Current
collection methods are laborious and typically require sacrificing the mosquito, limiting researchers to a
single saliva collection time point per insect. Inspired by the hanging blood drop and the field-oriented
honey-trap method, they are designing an approach that will allow collection of saliva from individual
mosquitoes during routine sugar feeds. They have systematically optimized this assay: including
methods of sucrose delivery, housing, timing, and detection of virus from samples. A 3D printed
lid covered with organdy turned 12-well plates into suitable habitats for both Anopheles gambiae and
Aedes aegypti, as they provided a compact living space for individual mosquitoes and improved safety
over cartons. To detect chikungunya virus from experimentally infected mosquitoes, quantitative
reverse-transcription real-time PCR, normalized to a standard curve, was performed on RNA purified
from mosquito saliva samples. This collection technique is a promising method for assaying arbovirus
transmission rates over time from experimentally infected mosquitoes as it facilitates rapid longitudinal
collection of infected saliva from individual mosquitoes. Also, by eliminating the need for glass
capillaries and reducing manipulation of mosquitoes, this technique improves biosafety, saves time
and allows for increased numbers of mosquitoes per experiment.
Michelina Meinzer (University of Wyoming, Laramie, WY, USA) demonstrated that climate
variables and maternal antibodies can affect the natural transmission of bluetongue virus in
range-pastured beef cattle. Bluetongue virus (BTV) is spread by members of the genus Culicoides
and infects domestic and wild ruminants. It may lead to a highly fatal hemorrhagic disease in
certain species, including mule deer, white-tailed deer, pronghorn, domestic sheep, and bighorn
sheep. Cattle are susceptible to infection but generally asymptomatic. This study examines the
effects of climate variables and maternal antibodies on the natural transmission of bluetongue virus
in range-pastured beef cattle. Each summer for three seasons, 20 maternal antibody positive and
20 maternal antibody negative spring-born calves were tested twice monthly for BTV antibodies using
competitive enzyme-linked immunosorbent assays and serum neutralization assays. To determine
the duration of passive protection, the rate of antibody decay was determined for maternal antibody
positive calves. Onset of infections was determined by seroconversion in maternal antibody negative
calves and detection of BTV RNA in the blood by real time-PCR (RT-PCR), followed by virus isolation
attempt from positive samples. Additionally, they collected Culicoides near the calves’ water source
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to determine weekly relative vector abundance and compared to climate variables on the day of
collection as well as 2–3 weeks prior. Based on our results, maternal antibodies in calves persist to
an average of 18.3 (range: 11.5–25.5) weeks of age. This likely helps protect spring-born calves from
disease in high-risk years with early transmission but will play a lesser role in protecting calves when
transmission occurs in late summer or fall. For the first two years of the study, BTV-17 was identified,
which has historically been the predominant serotype in Wyoming.
Alyssa Torres (Colorado State University, Pueblo, CO, USA) presented her data on West Nile
virus antibodies and dietary mercury levels in song birds collected from the Colorado Fountain Creek
region. West Nile virus (WNV) is a positive strand RNA virus (Flaviviridae) that is transmitted by
mosquitoes (Culex species). The virus is normally maintained and amplified in avian reservoir hosts,
but infected mosquitoes will also bite other vertebrates and can result in the transmission of the virus.
WNV infections have been reported all over North America, including recent infections in Colorado.
Mosquitoes are routinely sampled for the presence of WNV, but bird populations are more difficult to
trap and analyze. Mercury is a neurotoxin that has been shown to affect brain activity and immune
response in a variety of vertebrate species, including birds. One of the most common ways for mercury
to be acquired is by diet. Dietary mercury exposure has been associated with suppressed immune
responsiveness in captive song birds. They trapped and banded song birds and collected blood samples
in the Fountain Creek Region of Colorado in summers of 2014–2017. Blood samples are currently
being screened for mercury levels using a DMA 3000 Mercury analyzer and for WNV antibodies
using an indirect enzyme-linked immunosorbent assay (ELISA). They hypothesized that higher levels
of mercury may correlate with WNV infection. Initial screening results show multiple birds being
positive for WNV antibodies. Those same bird species have also shown higher levels of mercury than
the other species. Over 800 bird blood samples have been collected over the last four years and will
be analyzed for WNV antibodies and mercury. Geographic location, bird species, bird age, mercury
levels, and WNV antibody titer data will be gathered and analyzed for any correlations between WNV
exposure and blood mercury concentrations.
Molly Butler (Colorado State University, Fort Collins, CO, USA) identified a retrovirus that is
associated with thymic lymphoma in Gunnisons’s prairie dogs (Cynomys gunnisoni). The Gunnison’s
prairie dog is one of five species of prairie dogs native to North America. Prairie dogs are recognized
as “keystone” species in the ecosystem of Colorado, providing habitat for numerous ground-dwelling
birds and mammals, and serving as the major food source for several carnivorous species including the
endangered black-footed ferret. The most significant factor affecting survival of prairie dog species in
Colorado is epizootics of plague (caused by Yersinia pestis). Prairie dogs are highly sensitive to plague
infection, with death occurring rapidly in infected animals with no apparent clinical signs prior to
death from acute septicemia. Although all populations of prairie dogs are at risk for plague die-offs,
Gunnison’s prairie dogs have been extensively studied in Colorado. As part of plague research and
management efforts in Colorado, prairie dogs were captured from several colonies across the state.
Animals found dead or that died under anesthesia were given a full necropsy to determine cause
of death. As part of this effort, three Gunnison’s prairie dogs from Colorado were diagnosed with
thymic lymphoma. No other neoplastic disorders were identified in any of the prairie dogs examined.
We investigated the possibility that the cases of thymic lymphoma observed in Gunnison’s prairie
dogs were associated with retroviral infection. RNA was isolated from the tumors and spleens from
these animals and from spleens collected from two prairie dogs without a visible mass. Real time-PCR
(RT-PCR) using degenerate primers targeting conserved amino acid sequences (LPQG and YMDD)
in the reverse transcriptase gene was used to identify novel retroviral sequences from animals with
thymic lymphoma. Retroviral sequences were not amplified from the spleens of animals without a
mass. NextGen sequencing of RNA samples from tumor-positive and tumor-negative prairie dogs
yielded a retrovirus-like sequence which has a complete open reading frame (ORF) encoding for gag,
pro-pol, and env. The greatest number of reads of this sequence was found in tumor samples, in lower
numbers in spleen samples from tumor-positive prairie dogs, and was not found in tumor-negative
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prairie dog spleen samples. This represents a candidate for a novel retrovirus associated with thymic
lymphomas in prairie dogs.
Elliott Chiu (Colorado State University, Fort Collins, CO, USA) presented a study that
demonstrated Feline leukemia virus replicates faster in mountain lion cells. Feline leukemia virus
(FeLV) is a common domestic cat disease that has been documented in a range of wild felids. While the
progression of FeLV infection has been well documented in the domestic cats, infection has not been
thoroughly investigated in atypical hosts. In domestic cats, four types of infection (abortive, latent,
regressive, and progressive) have been documented. It has been hypothesized that the presence
and activity of the endogenous form of the virus (enFeLV) account for some differences in disease
phenotypes. Since the early 2000’s, Florida panthers (Puma concolor coryi) have experienced two
FeLV outbreaks, resulting in at least 29 unique infections. As Florida panthers lack enFeLV and that
viruses in naïve hosts may often be more virulent that in native hosts, they hypothesized that FeLV
viral load, proviral load, and viral replication will be greater in panthers compared to domestic cats.
They measured viral and proviral tissue loads by quantitative PCR (qPCR) in domestic cats and
panthers following natural and experimental infections in vivo as well as experimental infections
in vitro. Fibroblasts derived from panthers showed accelerated FeLV viral replication rates compared
to domestic cat fibroblasts, resulting in higher proviral load and productive viremia. Endpoint naturally
occurring FeLV-A infection in panthers had similar tissue viral loads to experimentally infected cats in
a small set of animals. Our research documents that FeLV-A can replicate with accelerated kinetics
in panther cells in vitro, but endpoint viral loads of panthers may be similar to that observed in
domestic cats.
Emily Feldman (University of Colorado, Boulder, CO, USA) described a project designed to
harness the genetic diversity of captive owl monkeys to study the special HIV variants that seed new
human infections. Human immunodeficiency virus-1 (HIV-1) transmission to a new individual elicits a
strong selective bottleneck on the existing virus population, and typically only one or few very special
viral variants establish each new infection. Only very recently have these transmitted/founder (T/F)
HIV-1 variants been appreciated for their unique ability to initiate an infection. The vast majority
of HIV-1 research has been performed utilizing lab-adapted or late-stage HIV-1 variants, which do
not recapitulate the cell-tropism, unique resistance to interferon and restriction factors, and antigenic
properties of T/F HIV-1 variants. Critically, the current animal model for HIV-1 infection and vaccine
research, the rhesus macaque, does not support the replication of T/F HIV-1. Many of the T/F HIV-1
variants are highly restricted by the macaque version of cluster of differentiation 4 (CD4), the HIV-1
entry receptor. Additionally, macaques block T/F HIV-1 replication at stages post-entry due to
several restriction factors with activity against HIV-1. Excitingly, their lab discovered the first monkey,
the Spix’s owl monkey, which encodes a CD4 that is broadly permissive for major global subtypes
of T/F HIV-1. Further, owl monkeys are only known to encode a minimal number of restriction
factors that block HIV-1, one of which (TRIM-Cyp) is evaded with a single point mutation in the HIV-1
genome, while another (tetherin) is polymorphic in owl monkeys with some individuals encoding
ineffective alleles. They harnessed the genetic diversity of multiple owl monkey colonies to define key
molecular interactions of T/F HIV-1 biology. Their preliminary data demonstrated that these studies
will expand our understanding of T/F HIV-1 biology.
Elena Judd (University of Colorado, Boulder, CO, USA) presented a study that investigated the
evolution of the interferon response across primates. Interferons and interferon-stimulated genes are
involved in a variety of mechanisms that suppress viral replication within host cells. Upon recognition
of a virus, a signaling cascade leads to the expression of secreted interferons. Interferons are then taken
up by neighboring cells, where they signal the increased expression of hundreds of downstream genes
that produce an antiviral cellular state. In turn, viruses have evolved strategies to subvert the interferon
response by evading recognition, impairing signaling, or hindering restrictive functions. Induction
genes and interferon-stimulated genes must evolve in turn to maintain an effective defense against
viruses in spite of high viral mutation rates. The tit-for-tat evolution between viruses and host proteins

Viruses 2017, 9, 333

22 of 26

creates a situation of coevolution. In this study, the Sawyer lab scanned interferon induction genes
and interferon-stimulated genes for signatures of natural selection using alignments of primate gene
sequences and the Phylogenetic Analysis by Maximum Likelihood (PAML) program. This program
uses different models of nucleotide substitution to detect loci which have accumulated significantly
elevated rates of nonsynonymous (amino acid altering) substitutions. They analyzed one hundred
interferon-stimulated genes and sixty interferon induction genes for positive selection. Interestingly,
interferon-stimulated genes had a significantly elevated rate of nonsynonymous mutations when
compared to the genes involved in interferon induction, and when compared to a set of random
genes. Induction genes were not elevated significantly when compared to the null set. Rapid
evolution may indicate that viruses are enhancing selective pressure for new mutations, specifically in
interferon-stimulated genes, and could provide a greater understanding of the host proteins important
for restriction of viral infection.
Laura Hoon-Hanks (Colorado State University, Fort Collins, CO, USA) presented their findings
regarding a respiratory disease in pythons experimentally infected with python nidovirus and other
updates on this emerging veterinary disease. A severe respiratory illness of pythons has been observed
by veterinarians since the 1990s. Circumstantial evidence has linked a novel python nidovirus to the
disease. They conducted an experimental infection in ball pythons (Python regius) to test the hypothesis
that ball python nidovirus (BPNV) infection would yield clinical signs and histologic lesions consistent
with respiratory disease. Additionally, they have investigated natural disease in mixed snake colonies,
providing further perspectives on this emerging veterinary disease. Five juvenile ball pythons were
inoculated: three with BPNV-infected medium and two with uninfected medium. Antemortem swabs
were performed weekly and tested for BPNV RNA by PCR. Euthanasia and postmortem examination
were performed on infected snakes at 5 weeks, 10 weeks, and 12 weeks post-inoculation (PI) based
on clinical signs. The most significant lesions in the infected snakes included chronic-active catarrhal
rhinitis, stomatitis, tracheitis, and esophagitis with variable epithelial proliferation and an interstitial
and proliferative pneumonia. Infectious virus was recovered from swabs and tissues from infected
snakes. Control snakes remained negative throughout the experiment and did not show clinical signs
or share histologic lesions. Their findings establish a causal relationship between BPNV infection and
respiratory disease in ball pythons. BPNV is part of an expanding group of related viruses that have
been associated with respiratory disease in reptiles and mammals. This work, as well as their additional
studies, has revealed insights into clinical course, possible routes of transmission, useful diagnostics,
viral genomic diversity, species specificity, and disease epidemiology of the python nidovirus.
Maryska Kaczmarek (University of Colorado, Boulder, CO, USA) demonstrated using their
results that C-C chemokine receptor type 5 (CCR5) is under recurrent positive selection, making
some primates resistant to infection by immunodeficiency viruses (human immunodeficiency virus
(HIV) and simian immunodeficiency cirus (SIV)). Cluster of differentiation 4 (CD4) and CCR5 are
the receptor and co-receptor that allow HIV and SIV to enter cells. CD4 has been shown to be
under recurrent positive selection, which has contributed to differences in primate susceptibility to
immunodeficiency virus entry. The evolution and functional relevance of species-specific differences
in CCR5 has largely been overlooked, partly due to the primary focus on CD4 as the cellular receptor
responsible for differences in viral entry. Here, they performed an evolutionary analysis with a large
dataset of primates and show that primate CCR5 also bears the signature of recurrent positive selection,
particularly within the New World Monkey clade. In addition, they have run site-specific models of
positive selection that identified sites in the N-terminus of CCR5, which are highly variable within
New World Monkeys. Amino acids in this region are sulfated and this modification is known to
be required for viral entry. Interestingly, they show that the sulfation motif is absent in New World
monkeys, and this contributes to lower levels of entry when a permissive CD4 is paired with a CCR5
from New World monkeys. New World Monkeys are not known to harbor any modern viruses related
to HIV and SIV, this suggests the compelling hypothesis that New World monkeys have acquired
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adaptive mutations in CCR5 that protect them from these viruses. Together, their work shows evidence
that CCR5 can pose as a barrier to cross-species transmission in primates.
Rebekah McMinn (Colorado State University, Fort Collins, CO, USA) expanded on the
knowledge base of Middle East respiratory syndrome coronavirus cross-species transmission through
studying the viral spike plasticity in the context of the common vampire bat (Desmodus rotundus)
dipeptidyl peptidase 4 (DPP4) receptor. In 2012, a novel coronavirus, Middle East respiratory
syndrome coronavirus (MERS-CoV), was discovered in humans and dromedary camels, although
genetic evidence supports a bat ancestor. This range of animal hosts lead them to hypothesize that
MERS-CoV can readily adapt to new hosts. The receptor for MERS-CoV, DPP4, has previously been
shown to act as a species barrier. By passing the virus over time on cells stably expressing the
common vampire bat DPP4 receptor, which MERS-CoV binds to inefficiently, they aimed to determine
how potential adaptation in the spike glycoprotein may influence species tropism. They showed
that observed adaptations that arise in the viral spike protein at residues 465 and 510 after extended
replication in cells expressing the bat DPP4 receptor. Protein structures that model electrostatic potential
across the surface were used to facilitate preliminary analysis of the adapted MERS-CoV Spike variants.
Viral genomes containing the relevant mutations are being created through a reverse genetics system
for further testing on binding affinity and growth potential. The ability of the MERS-CoV spike to
adapt to diverse host species receptors may play a significant role in cross-species transmission.
Megan Miller (Colorado State University, Fort Collins, CO, USA) used experimental infections to
determine if a sexual transmission model for Zika virus is possible. Zika virus (ZIKV) is a mosquito
borne flavivirus that has been prevalent in Asia, parts of Africa, and Central and South America.
The recent pandemic in South and North America resulted in over 1,000,000 cases. The most common
symptoms of Zika virus disease are rash, arthralgia, conjunctivitis and headache; however compilations
have been observed, including Guillain-Barre syndrome and birth defects, in infected newborns.
Interestingly, ZIKV is the only known flavivirus to be able to transmit sexually. This study was
undertaken to determine an immunecompetent, non-primate, small animal model that would be
valuable for understanding the mechanism of ZIKV sexual transmission. Previous published evidence
showed that cottontail rabbits seroconvert after inoculation with ZIKV, and other infection studies
suggested that both guinea pigs and the Jamaican fruit bats develop viremias and seroconvert after
inoculation. They are looking for evidence of infections in male tissues and body fluid of these
three animal models; rabbits (NZW strain), guinea pigs (Hartley strain) and the local colony of
Artibeus jamaicensis (Jamaican fruit bat). Groups of each species are being inoculated with ZIKV or
uninfected cell culture media, and then blood, oral swab, urine and semen samples are collected
and tested for ZIKV by quantitative real time-PCR (qRT-PCR) and plaque assays. To date, they have
determined that NZW rabbits are not a competent model for ZIKV sexual transmission. Additional
results are pending. By determining an immune-competent, non-primate, sexual transmission
animal model for ZIKV they hope to begin addressing many unknown questions about this mode of
transmission and its influence on ZIKV disease.
Jessica Costlow (Colorado State University, Pueblo, CO, USA) presented their exploration of
cancer metabolic inhibitor drugs as potential anti-viral treatments for alphaviruses. Alphaviruses
infect millions of people and animals. Chikungunya virus (CHIKV) is an arthritogenic alphavirus that
is currently outbreaking. Sindbis Virus (SINV) is a relative to CHIKV and acts as a widely accepted
model to study alphavirus infections. Viruses are obligate intracellular parasites and dependent on the
host cell. Alphaviruses take over the host cell and make dramatic changes to the normal cell physiology
in a number of cellular pathways, including an upregulation in glycolysis. Cancerous cells also display
an elevated metabolic phenotype which directly correlates to cancer development and metastasis.
There are several US Food and Drug Administration (FDA)-approved cancer drugs that target this
elevated metabolic rate and reduce it to normal levels and thereby slow or prevent cancer growth.
Two common cancer drugs listed by the National Cancer Institute that inhibit metabolism are Imatinib
and Dichloroacetate (DCA). They hypothesized that these FDA-approved cancer metabolic inhibitor
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compounds could be repurposed and used to treat virally infected cells. Since some Alphaviruses
have been shown to require an elevated metabolic rate for optimal replication, these drugs may reduce
metabolism and prevent viruses from replicating as effectively. Their results indicated that treatment
of SINV-infected Baby Hamster Kidney (BHK) cells with Imatinib and/or DCA show reduced viral
growth kinetics. Treatment with 12 µM of imatinib reduced the percentage of infected cells by
approximately 45% at 24 h post treatment, while maintaining normal cell viability on uninfected
cells. DCA treatment reduced viral titers but had to be used at much higher concentrations (greater
than 50 µM) to have any effect on infected cells as compared to imatinib treatment. Further testing
is currently ongoing to determine the optimal concentrations for DCA and imatinib to reduce
viral replication and still maintain cell viability. These results are promising and we are currently
investigating more details on the utility of these drugs as an anti-viral therapy.
Carmen Ledesma-Feliciano (Colorado State University, Fort Collins, CO, USA) presented work
on a vaccine system and found that Feline foamy virus Bet can be replaced by feline immunodeficiency
virus Vif in a novel chimeric vaccine system. Feline foamy virus (FFV) is a Spumavirus that has
not been associated with a disease syndrome in domestic cats despite life-long infection. Because
of this, FFV has potential use as a vaccine and gene therapy vector. In order to test the ability
of a replicative novel vaccine candidate to infect and induce an immune response, we inoculated
SPF domestic cats (n = 4/group) with wild-type (wt) FFV or a chimeric FFV-Vif virus containing
the feline immunodeficiency virus (FIV) vif gene replacing the FFV bet gene. Vif and Bet proteins
counteract intrinsic feline APOBEC3 (feA3) restriction factor proteins through different mechanisms.
FFV infection was confirmed in wt-inoculated cats as early as 21 days post-infection via PCR of
peripheral blood mononuclear cell (PBMC) DNA. Chimera-inoculated cats yielded either negative
or indeterminate results by day 53 post-inoculation. At this point, chimera-inoculated cats were
re-inoculated: two received more chimeric virus and two wt FFV. One of the cats re-inoculated
with wt virus was consistently FFV-positive 24 days following re-inoculation (PCR). Antigen-specific
ELISA demonstrated that all wt and chimera-inoculated cats seroconverted against FFV-Gag by day
28 post-inoculation. Quantification of anti-Gag immune response over time showed an increasing
titer in wt-inoculated cats that either continued to increase or plateau. Chimera-inoculated cats had
comparable anti-Gag antibody titers following re-inoculation. The four cats initially inoculated with
wt FFV seroconverted against Bet by 42 days post-inoculation, while the two chimera-inoculated cats
later exposed to wt FFV seroconverted by 45 days post-re-inoculation. Anti-Vif seroconversion in three
chimera-inoculated cats was detected 15 days post-inoculation and increased following re-inoculation
with either wt or FFV-Vif. These findings demonstrate that this chimeric vector system can induce
a detectable immune response in domestic cats comparable to wt infection, and that FFV is capable
of superinfection.
Joseph Lopez (Colorado State University, Pueblo, CO, USA) continued the theme of viral
targets and therapies by presenting their work on the impact of Cannabinoid Receptor (CB1)
Antagonism/Agonism on Alphavirus Replication. Cannabinoid receptors are found on many cells
throughout the body. Cannabinoids bind to the receptors and initiate a signaling cascade within the
cell. It has been shown that activation of cannabinoid receptors (CB1) alter cellular physiology
and increase anabolic pathways such as fatty acid and glucose synthesis. Viruses are obligate
intracellular parasites that require a host cell to provide essential macromolecules, nutrients, and
energy for replication. Alterations to metabolic pathways directly impact the ability of the virus to
successfully replicate and produce new virions. They hypothesized that activation or inhibition of the
CB1 receptor/endocannabinoid signaling pathway will cause specific changes in cellular physiology
which will directly impact alphavirus infection in cultured cells. To investigate their hypothesis,
they utilized murine and human cell lines to measure the impact of the endocannabinoid system on
alphavirus infection. At this point, all testing has been performed with the prototype alphavirus,
which is Sindbis virus. This is a plus strand RNA virus that is transmitted by infected mosquitoes.
SINV is a safe virus to be used for testing in a lab setting, but it is closely related to other mosquito
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viruses that are causing outbreaks around the world, including Chikungunya virus. All cells being
used have been confirmed to have CB1 receptors on the cells. They have tested the activation of
CB1 receptors (using the agonist/activator ACEA) and the inhibition of the receptors (using the
antagonist/inhibitor AM251) and have found that treatment with either the agonist or antagonist
cause significant changes to virus replication at 24 h post infection. They are also investigating the
change in CB1 receptor expression during chronic viral infection to measure different susceptibilities
that may be influenced by the endocannabinoid system. Specific details and results will be discussed.
Amy MacNeill (Colorado State University, Fort Collins, CO, USA) gave a presentation on their
work about the Safety of Recombinant Myxoma Virus Therapy in Dogs with Soft Tissue Sarcomas.
Many oncolytic viruses that are efficacious in murine models of cancer are ineffective in humans.
The outcomes of oncolytic virus treatment of dogs with spontaneous tumors may be better predictors
of human cancer response to treatment and may improve treatment options for dogs with cancer.
The objective of this study was to evaluate the safety of intratumoral injection of myxoma virus lacking
the serp2 gene (MYXV∆serp2) in dogs with spontaneous subcutaneous soft tissue sarcomas. To achieve
this, MYXV∆serp2 was injected intratumorally in five dogs with spontaneous soft tissue sarcoma.
Tumor volume, tumor biopsies, and blood, urine, feces, saliva, and swabs from the injection site of
the virus were collected at several time points following the injection of MYXV∆serp2 to evaluate
organ function, immune response, and virus distribution. Additionally, post-operative MYXV∆serp2
was administered to four dogs with grade II-III soft tissue sarcoma to determine if virotherapy would
decrease tumor recurrence. To date, no adverse effects have been observed in any canine cancer
patients following the MYXV∆serp2 therapy. No clinically significant changes in complete blood
profiles, serum chemistry analyses, or urinalyses were measured. Virus was detected by PCR in
some biopsied tumors, but virus shedding was not observed. Anti-MYXV antibodies were rarely
detected in dogs. These findings provided needed safety information to advance clinical trials using
MYXV∆serp2 to treat dogs with cancer. Future studies were outlined that would help determine if
oncolytic virotherapeutics that are efficacious in dogs are effective in human cancer patients.
Candace K. Mathiason (Department of Microbiology, Immunology and Pathology, Colorado
State University, Fort Collins, CO, USA) explored the natural transience of reproductive microbiota and
placental immune cell profiles on transplacental trafficking of infectious agents. Maternal infections
during pregnancy induce immune factors and present infectious agents to the maternal-fetal interface.
Prenatal exposures to infectious pathogens are increasingly recognized to play an important etiologic
role in the development of fetal disorders with lifelong effects, i.e., zika—severe brain defects
including microcephaly; influenza—marginalized immune responses, depression, and schizophrenia;
prions—asymptomatic carrier state. The hallmark of successful pregnancy includes a maternal
immunological profile skewed towards an anti-inflammatory response. Disruption of microbiota
has been linked to proinflammatory responses. It is known that the decidua immune cell profile and
the placental microbiome community transition throughout pregnancy. Yet, the relationships between
these responses and the impact their interactions have on transplacental trafficking are unknown.
To investigate the role altered placental microbiome and immune responses may play in facilitating or
inhibiting the transfer of infectious agents from mother to baby The Mathiason lab employ direct use of:
(i) reproductive tissue (uterus, placenta, vagina) microbiome analysis; (ii) decidua/fetal membrane flow
cytometric specific immune cell profile analysis; (iii) placental organotypic slice cultures and (iv) 3-D
culture of primary trophoblast cells. The overarching goal of this work was to answer the question:
How does the natural transience of the placental microbiome and/or immune cell profile exacerbate or
hinder pathogen transfer from mother to baby, and how can we take advantage of this to better design
preventative/therapeutic strategies?
2.6. Mentoring
Erica Suchman (Colorado State University, Fort Collins, CO, USA) presented her methods of
teacting virology that she has developed from nearly two decades on-site experience, and also from
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her interactions with the Committee on Technology Enhanced Education for the American Society of
Microbiology (Chairperson), the MicrobeLibrary, the American Society of Microbiology’s web based
peer reviewed education resource collection (Editor-in-chief, 2003–2012), and membership of both the
ASM Education Board and ASM committee on International Education. In her talk, mechanisms for
increasing student engagement and learning in both a large lecture and smaller laboratory virology
course were presented and discussed. In her current lectures, students analyze trends in taxonomy
for RNA and DNA viruses, concept mapping, and group exams, to move past memorization. In the
laboratory course students use pre-lab quizzing to prepare for daily labs, make predictions based on
phylogenetic trees, and perform blast searches on sequences to determine the identity of assigned
unknown viruses that augment laboratory activities. Examples and materials used in each type of
teaching environment were presented.
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